Amid international reports pointing out the decline in male sperm function, HDX Cell Bank Co., Ltd. (Headquarters: Tokyo, CEO: Toru Mukai) has launched WHO standard semen analysis and sperm DNA fragmentation index (DFI) tests as corporate health checkup options. Utilizing a home-based method with specialized collection and transport equipment, the tests can be conducted without the need for a clinic visit, drawing attention as a new initiative to visualize male reproductive function.
Background In recent years, the decline in male sperm function has been pointed out globally. On the other hand, in Japan, opportunities to understand one's own reproductive function are limited, and issues related to pregnancy and childbirth often only become apparent after entering the stage of fertility treatment. Furthermore, while women's awareness and options regarding reproductive health are advancing due to the spread of Femtech and egg freezing, the visualization on the male side is insufficient, creating an information gap between men and women. Against this background, there is a demand for foundational infrastructure that allows both men and women to jointly consider preparations for pregnancy and childbirth.
Service Overview This service offers the following tests as options for corporate health checkups and comprehensive medical examinations.
Provided Tests ・WHO Standard Semen Analysis (evaluates semen volume, sperm concentration, motility, etc.) ・Sperm DNA Fragmentation Index (DFI) Test (a precision test evaluating the degree of sperm DNA damage)
Implementation Method ・The test is conducted via a home delivery method using specialized collection and transport equipment. ・Samples collected at home are transported to the testing facility in temperature-controlled, dedicated containers, eliminating the need to visit a medical institution. ・This provides the tests in a more accessible format, lowering the psychological and time barriers that previously existed.
FACT BOX
- Source: PR TIMES
- Category: New Product